
Cardiovascular and soft tissue are manufactured by ePTFE and biomaterial.
Highlights
The global Cardiovascular and Soft Tissue Repair Patches market was valued at US$ 3042 million in 2022 and is anticipated to reach US$ 3995.5 million by 2029, witnessing a CAGR of 4.6% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Owing to the increasing prevalence of congenital heart diseases such as ventricular septal defect, atrial septal defect and common atrium, the cardiovascular and soft tissue repair patches market is expected to grow rapidly over the forecast period.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cardiovascular and Soft Tissue Repair Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular and Soft Tissue Repair Patches.
The Cardiovascular and Soft Tissue Repair Patches market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cardiovascular and Soft Tissue Repair Patches market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiovascular and Soft Tissue Repair Patches companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Cryolife
Edwards Life Sciences
Bard Peripheral Vascular
Baxter
Admedus
Neovasc
Southernlight Biomaterials
Segment by Type
EPTFE
Biomaterial
Tissue Engineered Material
Segment by Application
Cardiac Repair
Vascular Repair
Pericardial Repair
Dural Repair
Soft Tissue Repair
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiovascular and Soft Tissue Repair Patches companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiovascular and Soft Tissue Repair Patches Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 EPTFE
1.2.3 Biomaterial
1.2.4 Tissue Engineered Material
1.3 Market by Application
1.3.1 Global Cardiovascular and Soft Tissue Repair Patches Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cardiac Repair
1.3.3 Vascular Repair
1.3.4 Pericardial Repair
1.3.5 Dural Repair
1.3.6 Soft Tissue Repair
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiovascular and Soft Tissue Repair Patches Market Perspective (2018-2029)
2.2 Cardiovascular and Soft Tissue Repair Patches Growth Trends by Region
2.2.1 Global Cardiovascular and Soft Tissue Repair Patches Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cardiovascular and Soft Tissue Repair Patches Historic Market Size by Region (2018-2023)
2.2.3 Cardiovascular and Soft Tissue Repair Patches Forecasted Market Size by Region (2024-2029)
2.3 Cardiovascular and Soft Tissue Repair Patches Market Dynamics
2.3.1 Cardiovascular and Soft Tissue Repair Patches Industry Trends
2.3.2 Cardiovascular and Soft Tissue Repair Patches Market Drivers
2.3.3 Cardiovascular and Soft Tissue Repair Patches Market Challenges
2.3.4 Cardiovascular and Soft Tissue Repair Patches Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiovascular and Soft Tissue Repair Patches Players by Revenue
3.1.1 Global Top Cardiovascular and Soft Tissue Repair Patches Players by Revenue (2018-2023)
3.1.2 Global Cardiovascular and Soft Tissue Repair Patches Revenue Market Share by Players (2018-2023)
3.2 Global Cardiovascular and Soft Tissue Repair Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cardiovascular and Soft Tissue Repair Patches Revenue
3.4 Global Cardiovascular and Soft Tissue Repair Patches Market Concentration Ratio
3.4.1 Global Cardiovascular and Soft Tissue Repair Patches Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiovascular and Soft Tissue Repair Patches Revenue in 2022
3.5 Cardiovascular and Soft Tissue Repair Patches Key Players Head office and Area Served
3.6 Key Players Cardiovascular and Soft Tissue Repair Patches Product Solution and Service
3.7 Date of Enter into Cardiovascular and Soft Tissue Repair Patches Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiovascular and Soft Tissue Repair Patches Breakdown Data by Type
4.1 Global Cardiovascular and Soft Tissue Repair Patches Historic Market Size by Type (2018-2023)
4.2 Global Cardiovascular and Soft Tissue Repair Patches Forecasted Market Size by Type (2024-2029)
5 Cardiovascular and Soft Tissue Repair Patches Breakdown Data by Application
5.1 Global Cardiovascular and Soft Tissue Repair Patches Historic Market Size by Application (2018-2023)
5.2 Global Cardiovascular and Soft Tissue Repair Patches Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cardiovascular and Soft Tissue Repair Patches Market Size (2018-2029)
6.2 North America Cardiovascular and Soft Tissue Repair Patches Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cardiovascular and Soft Tissue Repair Patches Market Size by Country (2018-2023)
6.4 North America Cardiovascular and Soft Tissue Repair Patches Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiovascular and Soft Tissue Repair Patches Market Size (2018-2029)
7.2 Europe Cardiovascular and Soft Tissue Repair Patches Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cardiovascular and Soft Tissue Repair Patches Market Size by Country (2018-2023)
7.4 Europe Cardiovascular and Soft Tissue Repair Patches Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiovascular and Soft Tissue Repair Patches Market Size (2018-2029)
8.2 Asia-Pacific Cardiovascular and Soft Tissue Repair Patches Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cardiovascular and Soft Tissue Repair Patches Market Size by Region (2018-2023)
8.4 Asia-Pacific Cardiovascular and Soft Tissue Repair Patches Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiovascular and Soft Tissue Repair Patches Market Size (2018-2029)
9.2 Latin America Cardiovascular and Soft Tissue Repair Patches Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cardiovascular and Soft Tissue Repair Patches Market Size by Country (2018-2023)
9.4 Latin America Cardiovascular and Soft Tissue Repair Patches Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiovascular and Soft Tissue Repair Patches Market Size (2018-2029)
10.2 Middle East & Africa Cardiovascular and Soft Tissue Repair Patches Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cardiovascular and Soft Tissue Repair Patches Market Size by Country (2018-2023)
10.4 Middle East & Africa Cardiovascular and Soft Tissue Repair Patches Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cryolife
11.1.1 Cryolife Company Detail
11.1.2 Cryolife Business Overview
11.1.3 Cryolife Cardiovascular and Soft Tissue Repair Patches Introduction
11.1.4 Cryolife Revenue in Cardiovascular and Soft Tissue Repair Patches Business (2018-2023)
11.1.5 Cryolife Recent Development
11.2 Edwards Life Sciences
11.2.1 Edwards Life Sciences Company Detail
11.2.2 Edwards Life Sciences Business Overview
11.2.3 Edwards Life Sciences Cardiovascular and Soft Tissue Repair Patches Introduction
11.2.4 Edwards Life Sciences Revenue in Cardiovascular and Soft Tissue Repair Patches Business (2018-2023)
11.2.5 Edwards Life Sciences Recent Development
11.3 Bard Peripheral Vascular
11.3.1 Bard Peripheral Vascular Company Detail
11.3.2 Bard Peripheral Vascular Business Overview
11.3.3 Bard Peripheral Vascular Cardiovascular and Soft Tissue Repair Patches Introduction
11.3.4 Bard Peripheral Vascular Revenue in Cardiovascular and Soft Tissue Repair Patches Business (2018-2023)
11.3.5 Bard Peripheral Vascular Recent Development
11.4 Baxter
11.4.1 Baxter Company Detail
11.4.2 Baxter Business Overview
11.4.3 Baxter Cardiovascular and Soft Tissue Repair Patches Introduction
11.4.4 Baxter Revenue in Cardiovascular and Soft Tissue Repair Patches Business (2018-2023)
11.4.5 Baxter Recent Development
11.5 Admedus
11.5.1 Admedus Company Detail
11.5.2 Admedus Business Overview
11.5.3 Admedus Cardiovascular and Soft Tissue Repair Patches Introduction
11.5.4 Admedus Revenue in Cardiovascular and Soft Tissue Repair Patches Business (2018-2023)
11.5.5 Admedus Recent Development
11.6 Neovasc
11.6.1 Neovasc Company Detail
11.6.2 Neovasc Business Overview
11.6.3 Neovasc Cardiovascular and Soft Tissue Repair Patches Introduction
11.6.4 Neovasc Revenue in Cardiovascular and Soft Tissue Repair Patches Business (2018-2023)
11.6.5 Neovasc Recent Development
11.7 Southernlight Biomaterials
11.7.1 Southernlight Biomaterials Company Detail
11.7.2 Southernlight Biomaterials Business Overview
11.7.3 Southernlight Biomaterials Cardiovascular and Soft Tissue Repair Patches Introduction
11.7.4 Southernlight Biomaterials Revenue in Cardiovascular and Soft Tissue Repair Patches Business (2018-2023)
11.7.5 Southernlight Biomaterials Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Cryolife
Edwards Life Sciences
Bard Peripheral Vascular
Baxter
Admedus
Neovasc
Southernlight Biomaterials
Ìý
Ìý
*If Applicable.
